| RADIATION |
|
| Year : 2002 | Volume
: 22
| Issue : 2 | Page : 42-48 |
|
|
Immunomodulating effects of rasayana drugs in diabetics- A clinical study
Deepa Arora1, M Kumar1, SD Dubey2, Uaha Sings3
1 Department of Pharmacology, Universal College of Medical Sciences, Bhairahawa, Nepal
2 Department of Dravyaguna, I.M.S.B.H.U., Varanasi, India
3 Department of Immunopthology I.M.S., BH.U., Varanasi, India
Correspondence Address:
Deepa Arora
Department of Pharmacology, Universal College of Medical Sciences, Bhairahawa
Nepal
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Immune system plays an important role in pathogenesis of diabetes (DM). Besides hypoglycaemics, rasayanas are indicated in the management of DM. In several studies the immunomodulatroy potentials of rasayanas have been proved. A clinical trial of three rasayana drugs, Asparagus recemosus (AR). Bacopa monnieri (BM) and Centella asiatica (CA) was carried out in diabetics. In this study, diabetics were found to have significantly lower levels of serum IgG, increased serum IgA and comparable levels of IgM. All drugs reverted levels of serum IgG levels in diabetics, however, statistical significance was attained only with AR. Further the increased IgA levels were brought back towards normal. These drugs also increased serum protein levels. |
|
|
|
| [PDF]* |
|
 |
|
